
Keepit Achieves SOC 2 Type 1 in a Pivotal Move Toward Full SOC 2 Compliance
The SOC 2 Type 1 report, developed by the American Institute of Certified Public Accountants (AICPA), evaluates the design of an organization's internal controls related to key trust service principles at a specific point in time. This milestone provides assurance to customers that Keepit's security practices and controls are effectively designed to safeguard data — and meet industry expectations for enterprise-level protection.
'Achieving SOC 2 Type 1 attestation is a significant step forward in demonstrating our commitment to transparency, trust, and continuous improvement in how we protect customer data,' said Kim Larsen, Chief Information Security Officer at Keepit. 'It's a milestone that many of our customers — and prospects — have asked for, and we're proud to deliver.'
To complete the attestation, Keepit's Information Security and Legal teams worked closely with contributors from across the organization, including People and Culture, Quality Assurance, Delivery, Operations, Internal IT, and SOC teams. Together, they implemented and validated 108 distinct controls — covering the security and integrity of Keepit's systems and processes.
'Our success was a true cross-team effort,' added Larsen. 'It's a reflection of our commitment to protecting what matters most to our customers: their data.'
The SOC 2 Type 1 achievement builds on Keepit's ISO 27001 certification and further strengthens its position as the trusted choice for organizations seeking proven data protection and regulatory alignment. The next step is achieving the SOC 2 Type 2 report — a process already underway.
Customers, partners, and auditors can request access to the SOC 2 Type 1 report through Keepit's Customer Success and Support teams.
About Keepit
Keepit provides a next-level SaaS data protection platform purpose-built for the cloud. Securing data in a vendor-independent cloud safeguards essential business applications, boosts cyber resilience, and future-proofs data protection. Unique, separate, and immutable data storage with no sub-processors ensures compliance with local regulations and mitigates the impact of ransomware while guaranteeing continuous data access, business continuity, and fast and effective disaster recovery. Headquartered in Copenhagen with offices and data centers worldwide, more than 18,000 companies trust Keepit for its ease of use and effortless backup and recovery of cloud data.
For more information visit www.keepit.com or follow Keepit on LinkedIn.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
2 hours ago
- Business Wire
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces an increase in resources allocated to the liquidity contract entrusted to Kepler Cheuvreux. On 15 December 2017 Sensorion entered into a Liquidity Contract with Kepler Cheuvreux, modified by amendments dated 7 December 2018 and 15 July 2022 (the " Contract"). This Contract aims to promote the liquidity of the Shares of Sensorion on Euronext Paris. On 14 August 2025, in accordance with Article 4 of AMF Decision No. 2021-01 of 22 June 2021 renewing the establishment of liquidity contracts on equity securities as an accepted market practice, Sensorion increased the resources allocated to the liquidity contract by €60,000. Following this increase in resources, as of 14 August 2025, the following assets appear on the liquidity account: - 206,211 Sensorion Ordinary Shares - €66,965.21 About Sensorion Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders, a significant global unmet medical need. Sensorion has built a unique R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and mechanisms of action for drug candidates. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness, developed in the framework of its broad strategic collaboration focused on the genetics of hearing with the Institut Pasteur. SENS-501 (OTOF-GT) currently being developed in a Phase 1/2 clinical trial, targets deafness caused by mutations of the gene encoding for otoferlin and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. Sensorion's portfolio also comprises programs of a clinical-stage small molecule, SENS-401 (Arazasetron), for the treatment and prevention of hearing loss disorders. Sensorion's small molecule progresses in a Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) for the preservation of residual hearing. Sensorion, with partner Cochlear Limited, completed in 2024 a Phase 2a study of SENS-401 for the residual hearing preservation in patients scheduled for cochlear implantation. A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022. Disclaimer This press release contains certain forward-looking statements concerning Sensorion and its business. Such forward looking statements are based on assumptions that Sensorion considers to be reasonable. However, there can be no assurance that such forward-looking statements will be verified, which statements are subject to numerous risks, including the risks set forth in the 2024 full year report published on March 14, 2025, and available on our website and to the development of economic conditions, financial markets and the markets in which Sensorion operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Sensorion or not currently considered material by Sensorion. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Sensorion to be materially different from such forward-looking statements. This press release and the information that it contains do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, Sensorion shares in any country. The communication of this press release in certain countries may constitute a violation of local laws and regulations. Any recipient of this press release must inform oneself of any such local restrictions and comply therewith.


Business Wire
6 hours ago
- Business Wire
ESS Schedules Second Quarter 2025 Financial Results Conference Call
WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Tech, Inc. (ESS) (NYSE: GWH), a leading manufacturer of iron flow long-duration energy storage (LDES) systems for commercial- and utility-scale applications, today announced that it will hold a conference call on Thursday, August 14, 2025 at 5:00 p.m. EDT to discuss financial results for its second quarter 2025 ended June 30, 2025. The news release announcing the second quarter 2025 financial results will be disseminated on August 14, 2025 after the market closes. Interested parties may join the conference call beginning at 5:00 p.m. EDT on Thursday, August 14, 2025 via telephone by calling (833) 470-1428 in the U.S., or for international callers, by calling +1 (404) 975-4839 and entering conference ID 271308. A telephone replay will be available until August 21, 2025, by dialing (866) 813-9403 in the U.S., or for international callers, +1 (929) 458-6194 with conference ID 482125. A live webcast of the conference call will be available on ESS' Investor Relations website at A replay of the call will be available via the web at About ESS Tech, Inc. At ESS (NYSE: GWH), we deliver safe, sustainable, long-duration energy storage to ensure energy abundance and security. As energy demand continues to grow, our solutions provide essential reliability and resilience to people, communities, and businesses in the United States and throughout the world. Our technology uses earth-abundant iron, salt and water to deliver environmentally safe solutions capable of providing 10+ hours of flexible energy capacity for commercial and utility-scale energy storage applications. Established in 2011, ESS enables project developers, independent power producers, utilities and other large energy users to deploy reliable, sustainable long-duration energy storage solutions. For more information, visit


Forbes
6 hours ago
- Forbes
What The Future Of Human-AI Collaboration Could Look Like
On this episode of Forbes Talks, Forbes Associate Editor Alex York talks with CEO and Cofounder of Secfix, Fabiola Munguia. Munguia discusses her background, inspired by her entrepreneurial parents and witnessing cybersecurity trends at university. She started by selling ethical hacking services and then pivoted to building SEC Fix due to client demand for ISO 27,001 certification assistance. Munguia predicts that AI will increasingly automate workflows and be used to collect and document evidence for compliance. Most of SEC Fix's clients are European startups in information technology, and the company has secured $4.2 million in funding.